Skip to main content
Clinical Trials/CTRI/2023/07/055848
CTRI/2023/07/055848Not yet recruitingPhase 2

A Comparative Clinical Evaluation Of Virechana Karma With Aragvadhadi Avaleha And Kashmaryadi Kwatha In Vatarakta (Gouty Arthritis)

Dr Sonal0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients presenting with the clinical features of Vatarakta.
  • 2. Patients with either sex between the age group of 30 to 70 years.
  • 3. Patients fit for Virechana Karma.
  • 4. Patients showing the uric acid level above 6 mg/dl.
  • 5. Patients with chronicity of disease more than 6 month less than 5 years.

Exclusion Criteria

  • 1. Patients unfit for Virechana Karma.
  • 2. Patients with uncontrolled diabetes, HTN, systemic disorders and endocrine disorders and any other malignancy.
  • 3. Patients with autoimmune disease of joints.
  • 4. Patients with infection and communicable disease.
  • 5. Pregnant, lactating mother and menstruating females.
  • 6. Patients associated with rheumatoid arthritis, osteoarthritis.

Investigators

Sponsor
Dr Sonal

Similar Trials